Johnson & Johnson said Monday it expects to accelerate sales growth beyond Wall Street expectations in the field of ...
Johnson & Johnson (NYSE: JNJ) stock is up 1.8% in the five days after the company announced its $14.6 billion acquisition of ...
Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...
Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...
Johnson & Johnson (NYSE:JNJ) Declares a cash payout of $1.24 dividend per share on common stock for first quarter 2025, payable on 4th of March 2025 to shareholders that recorded on 18th of ...
Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement ...
These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.